AJCN EB Program 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Clin Nutr 89: 634-640, 2009. First published December 30, 2008; doi:10.3945/ajcn.2008.26445
American Journal of Clinical Nutrition, doi:10.3945/ajcn.2008.26445
Vol. 89, No. 2, 634-640, February 2009

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
89/2/634    most recent
ajcn.2008.26445v1
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sinotte, M.
Right arrow Articles by Brisson, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sinotte, M.
Right arrow Articles by Brisson, J.
Agricola
Right arrow Articles by Sinotte, M.
Right arrow Articles by Brisson, J.
© 2009 American Society for Clinical Nutrition

ORIGINAL RESEARCH COMMUNICATION

Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women

Marc Sinotte1,2,3, Caroline Diorio1,2,3, Sylvie Bérubé1,2,3, Michael Pollak1,2,3 and Jacques Brisson1,2,3

1 From the Département de Médecine Sociale et Préventive, Université Laval, Québec, Canada (MS, CD, and JB); the Unité de Recherche en Santé des Populations, Centre Hospitalier Affilié Universitaire de Québec, Québec, Canada (MS, CD, SB, and JB); the Centre des Maladies du sein Deschênes-Fabia, Centre Hospitalier Affilie Universitaire de Québec, Québec, Canada (CD, SB, and JB); and the Cancer Prevention Research Unit, Lady Davis Institute of the Jewish General Hospital and McGill University, Departments of Medicine and Oncology, Montréal, Canada (MP).

2 Supported in part by grant 4811-82 from the Canadian Breast Cancer Research Alliance, a grant from the Translation Acceleration Grants Program for Breast Cancer Control of the Canadian Breast Cancer Research Alliance and the Canadian Institutes of Health Research. MS was supported by studentships from the Canadian Institutes of Health Research and National Cancer Institute of Canada. CD was supported by a postdoctoral fellowships from the Cancer Research Society Inc and the Canadian Institutes of Health Research.

3 Reprints not available. Address correspondence to C Diorio, Unité de Recherche en Santé des Populations, Hôpital du Saint-Sacrement du Centre Hospitalier Affilié Universitaire de Québec, 1050 Chemin Sainte-Foy, Québec, Canada G1S 4L8. E-mail: caroline.diorio{at}uresp.ulaval.ca.

Background: Vitamin D status, determined on the basis of 25-hydroxyvitamin D [25(OH)D] concentrations, is associated with the risk of several diseases. Vitamin D binding protein (DBP) is the major carrier of vitamin D and its metabolites, but the role of DBP single nucleotide polymorphisms (SNPs) on 25(OH)D concentrations is unclear.

Objective: The objective was to evaluate the association of 2 DBP gene SNPs with 25(OH)D concentrations and explore whether such association varies according to the amount of vitamin D that needs to be transported.

Design: This cross-sectional study included 741 premenopausal white women, mostly of French descent. Plasma 25(OH)D concentrations were measured by radioimmunoassay. DBP-1 (rs7041) and DBP-2 (rs4588) were genotyped with a Sequenom MassArray platform. Associations and interactions were modeled by using multivariate linear regression.

Results: DBP-1 and DBP-2 SNPs were in strong linkage disequilibrium and were both associated with 25(OH)D concentrations. An additional copy of the rare allele of DBP-1 or DBP-2 was associated with lower 25(OH)D concentrations (β = –3.29, P for trend = 0.0003; β = –4.22, P for trend < 0.0001, respectively). These DBP polymorphisms explained as much of the variation in circulating 25(OH)D as did total vitamin D intake (r2 = 1.3% for DBP-1, r2 = 2.0% for DBP-2, and r2 ≤ 1.2% for vitamin D intake).

Conclusion: Circulating 25(OH)D concentrations in premenopausal women are strongly related to DBP polymorphisms. Whether DBP rare allele carriers have a different risk of vitamin D–related diseases and whether such carriers can benefit more or less from dietary interventions, vitamin D supplementation, or sun exposure need to be clarified.




This article has been cited by other articles:


Home page
PediatricsHome page
F. R. Greer
Defining Vitamin D Deficiency in Children: Beyond 25-OH Vitamin D Serum Concentrations
Pediatrics, November 1, 2009; 124(5): 1471 - 1473.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The American Society for Nutrition